Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Cell Reports
|
December 12, 2019
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Journal of Translational Medicine
|
July 24, 2019
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)
Paolo A Ascierto, Sanjiv S Agarwala, Gerardo Botti, et al.
Cancer Cell
|
August 20, 2021
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
Yujue Wang, Sixue Liu, Zhentao Yang, et al.
Nature Medicine
|
October 6, 2020
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
Alain P Algazi, Megan Othus, Adil I Daud, et al.
Nature
|
November 25, 2011
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, et al.
Journal of Translational Medicine
|
July 28, 2023
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)
Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
The Journal of Investigative Dermatology
|
July 27, 2019
Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting
Sancy A Leachman, Thomas J Hornyak, Greg Barsh, et al.
Nature Communications
|
August 2, 2016
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
Helena Escuin-Ordinas, Shuoran Li, Michael W Xie, et al.
Journal of Translational Medicine
|
July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)
Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Cell Reports
|
December 12, 2019
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Journal of Translational Medicine
|
July 24, 2019
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)
Paolo A Ascierto, Sanjiv S Agarwala, Gerardo Botti, et al.
Cancer Cell
|
August 20, 2021
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
Yujue Wang, Sixue Liu, Zhentao Yang, et al.
Nature Medicine
|
October 6, 2020
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
Alain P Algazi, Megan Othus, Adil I Daud, et al.
Nature
|
November 25, 2011
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I Poulikakos, Yogindra Persaud, Manickam Janakiraman, et al.
Journal of Translational Medicine
|
July 28, 2023
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)
Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
The Journal of Investigative Dermatology
|
July 27, 2019
Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting
Sancy A Leachman, Thomas J Hornyak, Greg Barsh, et al.
Nature Communications
|
August 2, 2016
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
Helena Escuin-Ordinas, Shuoran Li, Michael W Xie, et al.
Journal of Translational Medicine
|
July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)
Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Page
of 9